Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G-CSF for Adhesion Reformation After Hysteroscopic Adhesiolysis
NCT02855632Unknown
- Sponsor
- Sir Run-Run Shaw Hospital
- Start
- Aug 2016
- Primary completion
- Dec 2018
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Randomised trial of filgrastim in Intrauterine Adhesions (IUA) (2 arms), sponsored by Sir Run-Run Shaw Hospital. Primary endpoint: Adhesion reformation rate at 2 months. Status: unknown.
02
Drugs
filgrastim
03
Conditions
Intrauterine Adhesions (IUA)
Beyond the preview
Go deeper on NCT02855632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02855632.